Cargando…

The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives

OBJECTIVE: Clinical efficacy of cytostatic anticancer agents can be determined with the progression-free survival (PFS) ratio. This outcome measure compares PFS achieved by a new treatment (PFS2) to the PFS of the most recent treatment on which the patient has experienced progression (PFS1). Clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Kruis, Nienke, van der Ploeg, Phyllis, Wilting, Jody H.C., Caroline Vos, M., Thijs, Anna M.J., de Hullu, Joanne, Ottevanger, Petronella B., Lok, Christianne, Piek, Jurgen M.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309411/ https://www.ncbi.nlm.nih.gov/pubmed/35898197 http://dx.doi.org/10.1016/j.gore.2022.101035

Ejemplares similares

Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma
por: van Lieshout, Laura, et al.
Publicado: (2020)

Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma
por: van Lieshout, Laura, et al.
Publicado: (2021)

Analysis of computer-aided diagnostics in the preoperative diagnosis of ovarian cancer: a systematic review
por: Koch, Anna H., et al.
Publicado: (2023)

Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup
por: Roze, Joline, et al.
Publicado: (2020)

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
por: de Jong, Loek A. W., et al.
Publicado: (2023)

Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey
por: Steenbeek, Miranda P., et al.
Publicado: (2018)

Patients’ and professionals’ perspectives on implementation of opportunistic salpingectomy: a mixed-method study
por: Gelderblom, Malou E., et al.
Publicado: (2021)

Gastric cancer during pregnancy: A report on 13 cases and review of the literature with focus on chemotherapy during pregnancy
por: Maggen, Charlotte, et al.
Publicado: (2019)

First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants
por: Gelderblom, Malou E., et al.
Publicado: (2023)

Distinct Genomic Profiles Are Associated with Treatment Response and Survival in Ovarian Cancer
por: de Witte, Chris J., et al.
Publicado: (2022)

Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study
por: Said, Sherin A., et al.
Publicado: (2021)

Low incidence of pulmonary metastases in vulvar cancer patients: limited value of routine chest imaging based on a cohort study
por: Pleunis, N, et al.
Publicado: (2021)

Adequacy of family history taking in ovarian cancer patients: a population-based study
por: van Altena, Anne M., et al.
Publicado: (2012)

Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeing
por: Van de Beek, I., et al.
Publicado: (2019)

Cyclic activity of signal transduction pathways in fimbrial epithelium of the human fallopian tube
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Rationale of the BREAst cancer e-healTH [BREATH] multicentre randomised controlled trial: An Internet-based self-management intervention to foster adjustment after curative breast cancer by decreasing distress and increasing empowerment
por: van den Berg, Sanne W, et al.
Publicado: (2012)

Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry
por: Rietveld, Mark J. A., et al.
Publicado: (2018)

In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors
por: Roze, Joline, et al.
Publicado: (2021)

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer
por: van Stein, Ruby M., et al.
Publicado: (2023)

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer
por: van Bommel, Majke H.D., et al.
Publicado: (2022)

Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study
por: Said, Sherin A., et al.
Publicado: (2023)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol
por: Oostendorp, Linda JM, et al.
Publicado: (2011)

Healthcare professionals’ perspectives of barriers and facilitators in implementing physical activity programmes delivered to cancer survivors in a shared-care model: a qualitative study
por: IJsbrandy, Charlotte, et al.
Publicado: (2019)

Determinants of adherence to physical cancer rehabilitation guidelines among cancer patients and cancer centers: a cross-sectional observational study
por: IJsbrandy, Charlotte, et al.
Publicado: (2020)

Evaluation of two strategies to implement physical cancer rehabilitation guidelines for survivors of abdominopelvic cavity tumors: a controlled before-and-after study
por: IJsbrandy, Charlotte, et al.
Publicado: (2021)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review
por: Schuurman, Teska, et al.
Publicado: (2021)

Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study
por: Hendriks, Natasja, et al.
Publicado: (2022)

Systemic adverse events in imiquimod use for cervical intraepithelial neoplasia – A case series
por: Wouters, Tirza, et al.
Publicado: (2019)

CD34(+) progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg(null) mice
por: Van der Meer, Jolien M.R., et al.
Publicado: (2021)

Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer
por: Kastelein, Arnoud W., et al.
Publicado: (2020)

Cancer related maternal mortality and delay in diagnosis and treatment: a case series on 26 cases
por: de Haan, Jorine, et al.
Publicado: (2018)

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors
por: van Bommel, Majke H. D., et al.
Publicado: (2022)

Immunohistochemical expression of MMP-14 and MMP-2, and MMP-2 activity during human ovarian follicular development
por: Vos, Maria Caroline, et al.
Publicado: (2014)

Needs, Preferences, and Values during Different Treatment Decisions of Patients with Differentiated Thyroid Cancer
por: Koot, Anna, et al.
Publicado: (2021)

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing
por: Koot, Anna, et al.
Publicado: (2023)

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
por: van Gerwen, Mathilde, et al.
Publicado: (2021)

Patients’ Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist’s Awareness of These Preferences
por: Oostendorp, Linda J. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9rf7u1j0orf6hu4g287ikm8tj0